IMMUNIC, INC. Logo

IMMUNIC, INC.

Develops oral small molecule therapies for chronic inflammatory and autoimmune diseases.

IMUX | US

Overview

Corporate Details

ISIN(s):
US4525EP1011 (+1 more)
LEI:
549300R5T12FW5MEQB20
Country:
United States of America
Address:
1200 AVENUE OF THE AMERICAS, 10036 NEW YORK

Description

Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's mission is to create high-quality, oral treatment options that offer comprehensive therapeutic efficacy with favorable safety and tolerability profiles. Its clinical development programs target conditions with significant unmet medical needs, including multiple sclerosis and celiac disease, aiming to provide patients with convenient and effective solutions to manage debilitating symptoms and improve their quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-09 09:30 English ZIP 7.3 KB
2024-12-06 18:32 English ZIP 7.1 KB
2024-12-06 18:31 English ZIP 7.0 KB
2024-12-06 18:31 English ZIP 7.1 KB
2024-12-06 18:30 English ZIP 7.1 KB
2024-12-06 18:30
FORM 4
English ZIP 7.2 KB
2024-11-14 18:33 English ZIP 19.9 KB
2024-11-14 07:58 English ZIP 15.0 KB
2024-11-13 15:13 English ZIP 6.5 KB
2024-11-12 16:51 English ZIP 9.3 KB
2024-11-12 10:31
IMMUNIC, INC.
English ZIP 17.4 KB
2024-11-07 08:04
10-Q
English ZIP 9.2 MB
2024-11-07 07:45 English ZIP 5.1 MB
2024-11-04 12:49 English ZIP 8.5 KB
2024-10-22 08:45 English ZIP 4.4 MB

Automate Your Workflow. Get a real-time feed of all IMMUNIC, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMMUNIC, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMMUNIC, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.